FFA
PPH icon

Farther Finance Advisors’s VanEck Pharmaceutical ETF PPH Stock Holding History

Farther Finance Advisors’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$116K Sell
1,058
-28
-3% -$3.12K ﹤0.01% 2743
2026
Q2 		$119K Sell
1,086
-318
-23% -$32.9K ﹤0.01% 2597
2026
Q1 		$147K Buy
1,404
+686
+96% +$73.1K ﹤0.01% 2239
2025
Q4 		$74.1K Buy
718
+282
+65% +$27.4K ﹤0.01% 2539
2025
Q3 		$39.4K Buy
436
+2
+0.5% +$175 ﹤0.01% 2589
2025
Q2 		$38.2K Sell
434
-111
-20% -$9.62K ﹤0.01% 2277
2025
Q1 		$48.4K Buy
545
+434
+391% +$39.1K ﹤0.01% 1914
2024
Q4 		$9.58K Buy
111
+1
+0.9% +$90 ﹤0.01% 2401
2024
Q3 		$10.4K Buy
+110
New +$10.4K ﹤0.01% 2351

Other funds holding PPH

RBC
Rye Brook Capital Greenwich, Connecticut $154M AUM 17.54% 1-Year Est. Return
AWM
Avior Wealth Management Omaha, Nebraska $3.79B AUM 15.36% 1-Year Est. Return
IFG
Independent Financial Group San Diego, California $5.51B AUM 33.52% 1-Year Est. Return
IPAM
Investment Partners Asset Management Metuchen, New Jersey $186M AUM 19.73% 1-Year Est. Return
VIP
Value Investment Professionals New York $115M AUM 13% 1-Year Est. Return
EFG
Elm3 Financial Group Alpharetta, Georgia $150M AUM 21.63% 1-Year Est. Return
BWM
Bullock Wealth Management Bloomington, Indiana $241M AUM 23.31% 1-Year Est. Return
TC
Trust Company Manhattan, Kansas $1.15B AUM 7.83% 1-Year Est. Return

Farther Finance Advisors's PPH Position: Q3 2026 in Review

Farther Finance Advisors reduced its VanEck Pharmaceutical ETF (PPH) stake by 2.6% in Q3 2026, selling an estimated $3.12K and leaving 1,058 shares worth $116K. The position accounts for ﹤0.01% of the portfolio, ranked #2743.

Farther Finance Advisors first reported a position in PPH in Q3 2024 and has held it in 9 quarters since. The position peaked at $147K in Q1 2026. 9 funds tracked by Wall St. Rank hold PPH as of Q3 2026.

  • Farther Finance Advisors held 1,058 shares of VanEck Pharmaceutical ETF worth $116K as of Q3 2026.
  • Farther Finance Advisors sold 28 VanEck Pharmaceutical ETF shares in Q3 2026, an estimated $3.12K.
  • VanEck Pharmaceutical ETF made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #2743 holding.
  • Farther Finance Advisors first reported a position in VanEck Pharmaceutical ETF in Q3 2024 and has held it in 9 quarters since.
  • Farther Finance Advisors's VanEck Pharmaceutical ETF position peaked at $147K in Q1 2026.
  • 9 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.